about
Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study.Genetic loci associated with heart rate variability and their effects on cardiac disease risk.Genome-wide analysis identifies 12 loci influencing human reproductive behavior.Mendelian randomization of blood lipids for coronary heart disease.Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.Gene-centric meta-analysis of lipid traits in African, East Asian and Hispanic populations.Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk.Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis.Gene Set Enrichment Analyses: lessons learned from the heart failure phenotype.52 Genetic Loci Influencing Myocardial Mass.Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.Identifying gene-gene interactions that are highly associated with four quantitative lipid traits across multiple cohorts.Concept and design of a genome-wide association genotyping array tailored for transplantation-specific studiesSeventy-five genetic loci influencing the human red blood cellLoci influencing blood pressure identified using a cardiovascular gene-centric array.Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension.Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci.The ENCODE project and perspectives on pathways.Additional Candidate Genes for Human Atherosclerotic Disease Identified Through Annotation Based on Chromatin Organization.Discovery and replication of SNP-SNP interactions for quantitative lipid traits in over 60,000 individuals.A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors.Genomic correlates of glatiramer acetate adverse cardiovascular effects lead to a novel locus mediating coronary risk.Serum lipid levels, body mass index, and their role in coronary artery calcification: a polygenic analysis.Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk.
P50
Q30276065-4814C652-4DE3-4A0A-8CDC-7FB9559D158FQ30313100-047AFAF2-19D2-405D-ACD1-69B2F4D19C44Q30313778-636649DC-DA93-4DE0-A2AC-98F02F424BF5Q30407506-CED4ECE4-001C-4C27-A2AD-5DF317B6030CQ30419436-6AD6E3E9-EBE9-4616-96F8-AA779EFAA6DBQ30423388-D2EF3723-0CC2-4B77-BEDD-D720EE8C470DQ31053398-D278F13E-1976-4B98-AEB2-F67EDAA28CA9Q33673402-EBBC32D9-97B2-4604-B3E4-8297495E5AC8Q33733871-BF26F0BC-5A1F-42E6-B6A3-B0864E23C2AAQ33817558-932B0412-BE4E-4442-B39A-E731CD06EC20Q34495057-CD59564E-25D9-411A-B99D-0938FE1E5E30Q34544753-CFF8D958-7A6F-4BCC-B5B5-C6691C9BC56DQ36110086-BB7A52D7-CD8F-41CA-9A82-D1CA55246004Q36758500-C0E002D8-C54E-49FB-BF4A-52C046BDE694Q36853815-5185C057-ED63-46D1-AB9F-8BB25F84CE9AQ37324554-5A154058-1E51-4C6C-BCE1-F9F66DAA96C6Q37634121-FD6E7E93-DC13-4809-9558-7E2FB68F0707Q38203849-79A41C1B-6692-4395-8514-84FD8ABD467BQ38711485-0C01BE1B-C414-4C6A-9EC9-4C901159AD57Q39074820-42F736EE-62CE-4BA8-8C11-0E296071EB86Q40062073-95536558-010D-4FE0-8918-10E7426106B7Q40075332-613A9018-ACFD-45BC-81DB-723A6B82895BQ41596376-CA40BBCF-F327-412E-B6BF-0A38D3A6C8EAQ42342101-521E230B-1903-4B6A-ABC5-26BCBE07740B
P50
description
onderzoeker
@nl
name
Vinicius Tragante
@ast
Vinicius Tragante
@en
Vinicius Tragante
@es
Vinicius Tragante
@nl
Vinicius Tragante
@sl
type
label
Vinicius Tragante
@ast
Vinicius Tragante
@en
Vinicius Tragante
@es
Vinicius Tragante
@nl
Vinicius Tragante
@sl
prefLabel
Vinicius Tragante
@ast
Vinicius Tragante
@en
Vinicius Tragante
@es
Vinicius Tragante
@nl
Vinicius Tragante
@sl
P106
P21
P31
P569
2000-01-01T00:00:00Z